TCL Archive Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds April 13, 2012
TCL Archive Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer October 6, 1989
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive FCRF Contracts Recompetition Will Be Along Same Lines As in 1982 But for at Least Seven Years July 5, 1985
